Gene Activity List


Gene Activity List

Gene Compound Assay Inh Ic50 Ki View
sodium channel, voltage-gated, type I, beta QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel associated protein 1 QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel associated protein 2 QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
amiloride-sensitive cation channel 5, intestinal QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type VIII, alpha polypeptide QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha polypeptide QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha polypeptide QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 gamma QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 beta QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, gamma QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, delta QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type X, alpha QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 IMATINIB Adenosine Transporter 45% NoneNone NoneNone View
concentrative Na+ nucleoside cotransporter (DBSS) IMATINIB Adenosine Transporter 45% NoneNone NoneNone View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 IMATINIB Adenosine Transporter 45% NoneNone NoneNone View
adenine nucleotide translocase (DBSS) (Non-specific probe) IMATINIB Adenosine Transporter 45% NoneNone NoneNone View
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 IMATINIB Adenosine Transporter 45% NoneNone NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) 3-METHYLCHOLANTHRENE Protein Tyrosine Kinase, HER2 Receptor 48% NoneNone NoneNone View
adrenergic receptor, alpha 1a U-78517F Adrenergic alpha1A 48% NoneNone NoneNone View
estrogen receptor 1 CLOTRIMAZOLE Estrogen ERalpha 48% NoneNone NoneNone View
estrogen receptor 1 CLOTRIMAZOLE Estrogen ERalpha 48% NoneNone NoneNone View
mitogen activated protein kinase 14 TRETINOIN Protein Serine/Threonine Kinase, p38alpha 48% NoneNone NoneNone View
mitogen-activated protein kinase 14 TRETINOIN Protein Serine/Threonine Kinase, p38alpha 48% NoneNone NoneNone View
Cytochrom P450-1A2 monooxygenase DIHYDROERGOTAMINE CYP450-1A2 Inhibition 48% NoneNone NoneNone View
cytochrome P450, family 3, subfamily a, polypeptide 13 PRALIDOXIME CHLORIDE CYP450-3A4 Inhibition 48% NoneNone NoneNone View
potassium voltage-gated channel, subfamily H (eag-related), member 3 CYPROHEPTADINE Potassium Channel HERG 48% 17.0491uM 13.9679uM View
potassium voltage-gated channel, subfamily H (eag-related), member 4 CYPROHEPTADINE Potassium Channel HERG 48% 17.0491uM 13.9679uM View
potassium voltage-gated channel, subfamily H (eag-related), member 1 CYPROHEPTADINE Potassium Channel HERG 48% 17.0491uM 13.9679uM View
potassium voltage-gated channel, subfamily H (eag-related), member 1 CYPROHEPTADINE Potassium Channel HERG 48% 17.0491uM 13.9679uM View
potassium voltage-gated channel, subfamily H, member 8 CYPROHEPTADINE Potassium Channel HERG 48% 17.0491uM 13.9679uM View
potassium voltage-gated channel, subfamily H (eag-related), member 6 CYPROHEPTADINE Potassium Channel HERG 48% 17.0491uM 13.9679uM View
potassium voltage-gated channel, subfamily H (eag-related), member 7 CYPROHEPTADINE Potassium Channel HERG 48% 17.0491uM 13.9679uM View
potassium voltage-gated channel, subfamily H (eag-related), member 2 CYPROHEPTADINE Potassium Channel HERG 48% 17.0491uM 13.9679uM View
potassium voltage-gated channel, subfamily H (eag-related), member 5 CYPROHEPTADINE Potassium Channel HERG 48% 17.0491uM 13.9679uM View
Cytochrom P450-2C19 monooxygenase BW-723C86 CYP450-2C19 Inhibition 48% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 1A HEXACHLOROPHENE Serotonin 5-HT1A 48% NoneNone NoneNone View
A3 adenosine receptor PERHEXILINE Adenosine A3 48% NoneNone NoneNone View
opioid receptor, sigma 1 DESLORATADINE Sigma1 48% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2B 4-NONYLPHENOL Serotonin 5-HT2B 48% NoneNone NoneNone View
mitogen activated protein kinase 1 FLUNOXAPROFEN Protein Serine/Threonine Kinase, ERK2 48% NoneNone NoneNone View
mitogen-activated protein kinase 1 FLUNOXAPROFEN Protein Serine/Threonine Kinase, ERK2 48% NoneNone NoneNone View
cholinergic receptor, muscarinic 1 HYDROXYCHLOROQUINE Muscarinic M1 48% NoneNone NoneNone View
histamine receptor H 2 CYCLIZINE Histamine H2 48% NoneNone NoneNone View
Cytochrom P450-2D6 monooxygenase MOXONIDINE CYP450-2D6 Inhibition 48% NoneNone NoneNone View
Cytochrom P450-2D6 monooxygenase VECURONIUM BROMIDE CYP450-2D6 Inhibition 48% NoneNone NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) EBASTINE CYP450-2C9 Inhibition 48% NoneNone NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 EBASTINE CYP450-2C9 Inhibition 48% NoneNone NoneNone View
Cytochrom P450-2D6 monooxygenase GUANABENZ CYP450-2D6 Inhibition 48% NoneNone NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) FLUORESCEIN CYP450-2C9 Inhibition 48% NoneNone NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 FLUORESCEIN CYP450-2C9 Inhibition 48% NoneNone NoneNone View
acetylcholinesterase (YT blood group) CINNARIZINE Acetylcholinesterase 48% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta PUROMYCIN Sodium Channel, Site 2 12% NoneNone NoneNone View
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase CINNARIZINE Acetylcholinesterase 48% NoneNone NoneNone View
acetylcholinesterase CINNARIZINE Acetylcholinesterase 48% NoneNone NoneNone View
cathepsin G 3,3',4',5-TETRACHLOROSALICYLANILIDE Protease, Cathepsin G 48% NoneNone NoneNone View
mast cell protease 9 3,3',4',5-TETRACHLOROSALICYLANILIDE Protease, Cathepsin G 48% NoneNone NoneNone View
epidermal growth factor receptor FENBENDAZOLE Protein Tyrosine Kinase, EGF Receptor 48% NoneNone NoneNone View
leukotriene B4 receptor 2 CLOSANTEL Leukotriene B4 48% NoneNone NoneNone View
leukotriene B4 receptor CLOSANTEL Leukotriene B4 48% NoneNone NoneNone View
leukotriene B4 receptor CLOSANTEL Leukotriene B4 48% NoneNone NoneNone View
leukotriene B4 receptor 2 CLOSANTEL Leukotriene B4 48% NoneNone NoneNone View
adrenergic receptor, alpha 2a GRAMICIDIN Adrenergic alpha2A 48% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 GRAMICIDIN Dopamine Transporter 48% NoneNone NoneNone View
androgen receptor GRAMICIDIN Testosterone 48% NoneNone NoneNone View
neuropeptide Y receptor Y2 DIGITONIN Neuropeptide Y2 48% NoneNone NoneNone View
neuropeptide Y receptor Y2 DIGITONIN Neuropeptide Y2 48% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 ABAMECTIN Dopamine Transporter 48% NoneNone NoneNone View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 ERGOTAMINE Adenosine Transporter 48% NoneNone NoneNone View
concentrative Na+ nucleoside cotransporter (DBSS) ERGOTAMINE Adenosine Transporter 48% NoneNone NoneNone View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 ERGOTAMINE Adenosine Transporter 48% NoneNone NoneNone View
adenine nucleotide translocase (DBSS) (Non-specific probe) ERGOTAMINE Adenosine Transporter 48% NoneNone NoneNone View
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 ERGOTAMINE Adenosine Transporter 48% NoneNone NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) ERGOTAMINE Protein Tyrosine Kinase, HER2 Receptor 48% NoneNone NoneNone View
sodium channel, voltage-gated, type VIII, alpha polypeptide CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha polypeptide CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha polypeptide CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 gamma CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 beta CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, gamma CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, delta CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, voltage-gated, type X, alpha CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, voltage gated, type VIII, alpha CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, voltage-gated, type III, alpha CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, voltage-gated, type II, alpha 2 CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
histamine receptor H 1 RALOXIFENE Histamine H1, Central 46% NoneNone NoneNone View
Protein-tyrosine kinase, Fyn SB-203580 Protein Tyrosine Kinase, Fyn 46% NoneNone NoneNone View
thromboxane A synthase 1 ASTEMIZOLE Thromboxane Synthetase 46% NoneNone NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) ASTEMIZOLE Thromboxane Synthetase 46% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 1A CLOMIPHENE Serotonin 5-HT1A 46% NoneNone NoneNone View
cholinergic receptor, muscarinic 1 DROPERIDOL Muscarinic M1 46% NoneNone NoneNone View
cholinergic receptor, muscarinic 4 PIPAMAZINE Muscarinic M4 46% NoneNone NoneNone View
angiotensin II receptor, type 2 RAMIPRIL Angiotensin AT2 46% NoneNone NoneNone View
thromboxane A synthase 1 LOPERAMIDE Thromboxane Synthetase 46% NoneNone NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) LOPERAMIDE Thromboxane Synthetase 46% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2C MEXILETINE Serotonin 5-HT2C 46% NoneNone NoneNone View
lymphocyte protein tyrosine kinase (mapped) RWJ-68354 Protein Tyrosine Kinase, Lck 46% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 4-(PHENYLMETHYL)-1-[2-(TRIFLUOROMETHYL)BENZOYL]-PIPERIDINE Dopamine Transporter 46% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 N,N'-DIPHENYL-P-PHENYLENEDIAMINE Dopamine Transporter 46% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta IMIQUIMOD Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel associated protein 1 IMIQUIMOD Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel associated protein 2 IMIQUIMOD Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta IMIQUIMOD Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha IMIQUIMOD Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha IMIQUIMOD Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha IMIQUIMOD Sodium Channel, Site 2 46% NoneNone NoneNone View
amiloride-sensitive cation channel 5, intestinal IMIQUIMOD Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta IMIQUIMOD Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, voltage-gated, type VIII, alpha polypeptide IMIQUIMOD Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha IMIQUIMOD Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta IMIQUIMOD Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide IMIQUIMOD Sodium Channel, Site 2 46% NoneNone NoneNone View
adrenergic receptor, alpha 2b NELFINAVIR Adrenergic alpha2C 45% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) NELFINAVIR Adrenergic alpha2C 45% NoneNone NoneNone View
dopamine receptor D3 PYRILAMINE Dopamine D3 45% NoneNone NoneNone View
adrenergic receptor, alpha 1a PAROXETINE Adrenergic alpha1A 45% NoneNone NoneNone View
Cytochrom P450-2C19 monooxygenase VX-745 CYP450-2C19 Inhibition 45% NoneNone NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) VX-745 CYP450-2C9 Inhibition 45% NoneNone NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 VX-745 CYP450-2C9 Inhibition 45% NoneNone NoneNone View
epidermal growth factor receptor TERCONAZOLE Protein Tyrosine Kinase, EGF Receptor 45% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 1B TERBINAFINE Serotonin 5-HT1B 45% NoneNone NoneNone View
chemokine (C-C motif) receptor 2 STANOLONE Chemokine CCR2B 45% NoneNone NoneNone View
cholinergic receptor, muscarinic 4 TACRINE Muscarinic M4 45% NoneNone NoneNone View
mitogen activated protein kinase 1 ROSIGLITAZONE Protein Serine/Threonine Kinase, ERK2 45% NoneNone NoneNone View
mitogen-activated protein kinase 1 ROSIGLITAZONE Protein Serine/Threonine Kinase, ERK2 45% NoneNone NoneNone View
adrenergic receptor, alpha 2a PRILOCAINE Imidazoline I2, Central 45% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) PRILOCAINE Imidazoline I2, Central 45% NoneNone NoneNone View
histamine receptor H 2 PIOGLITAZONE Histamine H2 45% NoneNone NoneNone View
adrenergic receptor, alpha 2b 1,3-DIPHENYLGUANIDINE Adrenergic alpha2B 45% NoneNone NoneNone View
adrenergic receptor, alpha 2a PINDOLOL Adrenergic alpha2A 45% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 1B PINDOLOL Serotonin 5-HT1B 45% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
potassium voltage-gated channel, subfamily H, member 8 CITALOPRAM Potassium Channel HERG 45% 16.6754uM 13.6618uM View
potassium voltage-gated channel, subfamily H (eag-related), member 6 CITALOPRAM Potassium Channel HERG 45% 16.6754uM 13.6618uM View
potassium voltage-gated channel, subfamily H (eag-related), member 7 CITALOPRAM Potassium Channel HERG 45% 16.6754uM 13.6618uM View
potassium voltage-gated channel, subfamily H (eag-related), member 2 CITALOPRAM Potassium Channel HERG 45% 16.6754uM 13.6618uM View
potassium voltage-gated channel, subfamily H (eag-related), member 5 CITALOPRAM Potassium Channel HERG 45% 16.6754uM 13.6618uM View
potassium voltage-gated channel, subfamily H (eag-related), member 3 CITALOPRAM Potassium Channel HERG 45% 16.6754uM 13.6618uM View
potassium voltage-gated channel, subfamily H (eag-related), member 4 CITALOPRAM Potassium Channel HERG 45% 16.6754uM 13.6618uM View
potassium voltage-gated channel, subfamily H (eag-related), member 1 CITALOPRAM Potassium Channel HERG 45% 16.6754uM 13.6618uM View
potassium voltage-gated channel, subfamily H (eag-related), member 1 CITALOPRAM Potassium Channel HERG 45% 16.6754uM 13.6618uM View
cholinergic receptor, muscarinic 2 TRANS-PLATINUM(II)DIAMMINE DICHLORIDE Muscarinic M2 45% NoneNone NoneNone View
histamine receptor H 1 PERHEXILINE Histamine H1, Central 45% NoneNone NoneNone View
tachykinin receptor 2 PERHEXILINE Tachykinin NK2 45% NoneNone NoneNone View
melanocortin 5 receptor PERHEXILINE Melanocortin MC5 45% NoneNone NoneNone View
endothelin receptor type A PERHEXILINE Endothelin ETA 45% NoneNone NoneNone View
Sigma-2 Receptor IMATINIB Sigma2 45% NoneNone NoneNone View
cholinergic receptor, muscarinic 4 HYDROXYCHLOROQUINE Muscarinic M4 45% NoneNone NoneNone View
adrenergic receptor, alpha 2a DOMPERIDONE Imidazoline I2, Central 45% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) DOMPERIDONE Imidazoline I2, Central 45% NoneNone NoneNone View
adrenergic receptor, alpha 2a FLUNARIZINE Imidazoline I2, Central 45% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) FLUNARIZINE Imidazoline I2, Central 45% NoneNone NoneNone View
histamine receptor H 2 CINNARIZINE Histamine H2 45% NoneNone NoneNone View
dopamine receptor D3 DIMENHYDRINATE Dopamine D3 45% NoneNone NoneNone View
dopamine receptor D1A CYCLIZINE Dopamine D1 45% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 2 ZAFIRLUKAST Cyclooxygenase COX-2 45% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) ZAFIRLUKAST Cyclooxygenase COX-2 45% NoneNone NoneNone View
cytochrome P450, family 3, subfamily a, polypeptide 13 DOXAPRAM CYP450-3A4 Inhibition 45% NoneNone NoneNone View
Cytochrom P450-2D6 monooxygenase SPIRONOLACTONE CYP450-2D6 Inhibition 45% NoneNone NoneNone View
Cytochrom P450-2D6 monooxygenase METHYSERGIDE CYP450-2D6 Inhibition 45% NoneNone NoneNone View
Cytochrom P450-2C19 monooxygenase CILOSTAZOL CYP450-2C19 Inhibition 45% NoneNone NoneNone View
cholinergic receptor, muscarinic 4 BERBERINE CHLORIDE Muscarinic M4 45% NoneNone NoneNone View
caspase 1 RIFAPENTINE Protease, Caspase 1 45% NoneNone NoneNone View
caspase 1, apoptosis-related cysteine protease (interleukin 1, beta, convertase) RIFAPENTINE Protease, Caspase 1 45% NoneNone NoneNone View
caspase 3, apoptosis related cysteine protease RIFAPENTINE Protease, Caspase 1 45% NoneNone NoneNone View
caspase 2 RIFAPENTINE Protease, Caspase 1 45% NoneNone NoneNone View
caspase 7 RIFAPENTINE Protease, Caspase 1 45% NoneNone NoneNone View